Kenneth Spielvogel
Obstetrics & Gynecology · Long Beach, CANPI 1235104605
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $606 and has fallen 94.3% since, to $34 in 2025.
Across 93 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$424
- Johnson & Johnson$280
- GSK$142
- Pulmonx Corporation$127
- Astellas Pharma US Inc$125
- Bayer$75
- plus $732 from 24 others
What the payments were for
- Food & beverage$1,86698%
- Education$382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $424 |
| Johnson & Johnson(3 entities) | 12 | $280 |
| GSK | 8 | $142 |
| Pulmonx Corporation | 6 | $127 |
| Astellas Pharma US Inc | 1 | $125 |
| Bayer | 4 | $75 |
| Pfizer | 4 | $70 |
| Grifols USA, LLC | 3 | $59 |
| AstraZeneca(2 entities) | 3 | $55 |
| Covidien LP | 2 | $53 |
| Novo Nordisk | 3 | $40 |
| Merck | 2 | $38 |
| Coopersurgical, Inc. | 2 | $38 |
| Exeltis, USA Inc. | 2 | $37 |
| Hologic Sales And Service, LLC | 2 | $37 |
| Therapeuticsmd, Inc. | 2 | $29 |
| Boehringer Ingelheim | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $27 |
| Sage Therapeutics, LLC | 1 | $22 |
| AMAG Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Amgen | 1 | $20 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Olympus America Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Viiv Healthcare Company | 1 | $16 |
| Si-bone, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $14 |
How this compares
$1,904 in reported general payments places this provider in the 75th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| YuvafemEstradiol | 14 | $1,458 |
| DottiEstradiol | 21 | $1,322 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Long Beach
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.